Showing results (1561-1570 of 4,783) with videos related to
Sort By:
Pageof 479
Drug Discovery Today|October 11, 2019
Chemometrics: a complementary tool to guide the isolation of pharmacologically active natural productsAxhell A Cornejo-Báez, Luis M Peña-Rodríguez, Radamés Álvarez-Zapata, et al.Drug Discovery Today|October 16, 2019
Heterogeneous surface-modified nanoplatforms for the targeted therapy of haematological malignanciesSanjay Kulkarni, Abhijeet Pandey, Srinivas MutalikDrug Discovery Today|April 9, 2019
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation developmentHovhannes J Gukasyan, Shumet Hailu, Thomas K Karami, et al.Drug Discovery Today|September 4, 2018
The use of nanoparticles as biomaterials in dentistryRanjeet A Bapat, Chaitanya P Joshi, Prachi Bapat, et al.Drug Discovery Today|September 24, 2018
Bile acid homeostasis paradigm and its connotation with cholestatic liver diseasesTingting Yang, Ghulam Jilany Khan, Ziteng Wu, et al.Drug Discovery Today|September 24, 2018
Safety differentiation: emerging competitive edge in drug developmentMarianne Uteng, Laszlo Urban, Dominique Brees, et al.Drug Discovery Today|September 24, 2018
Biosimilar medicines used for cancer therapy in Europe: a reviewSofia B Santos, José M Sousa Lobo, Ana C SilvaDrug Discovery Today|May 18, 2018
Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cellsLakhveer Singh, Sara Aldosary, Abdulaziz S Saeedan, et al.Drug Discovery Today|May 19, 2018
Current approaches to the discovery of novel inhaled medicinesPeter Strong, Kazuhiro Ito, John Murray, et al.Drug Discovery Today|May 21, 2018
Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesisJenny Hering, Elin Dunevall, Margareta Ek, et al.Pageof 479